| Beta-blockers in cirrhosis: Evidence-based indications and limitations SG Rodrigues, YP Mendoza, J Bosch JHEP reports 2 (1), 100063, 2020 | 153 | 2020 |
| Monitoring occurrence of liver-related events and survival by transient elastography in patients with nonalcoholic fatty liver disease and compensated advanced chronic liver … S Petta, G Sebastiani, M Viganò, J Ampuero, VWS Wong, J Boursier, ... Clinical gastroenterology and hepatology 19 (4), 806-815. e5, 2021 | 124 | 2021 |
| Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta … FE Mózes, JA Lee, Y Vali, O Alzoubi, K Staufer, M Trauner, R Paternostro, ... The Lancet Gastroenterology & Hepatology 8 (8), 704-713, 2023 | 82 | 2023 |
| Inflammatory activity affects the accuracy of liver stiffness measurement by transient elastography but not by two‐dimensional shear wave elastography in non‐alcoholic fatty … YP Mendoza, SG Rodrigues, MG Delgado, G Murgia, NF Lange, ... Liver international 42 (1), 102-111, 2022 | 27 | 2022 |
| Liver‐related and extrahepatic events in patients with non‐alcoholic fatty liver disease: a retrospective competing risks analysis G Pennisi, M Enea, M Romero‐Gomez, M Viganò, E Bugianesi, ... Alimentary pharmacology & therapeutics 55 (5), 604-615, 2022 | 25 | 2022 |
| Noninvasive markers of portal hypertension detect decompensation in overweight or obese patients with compensated advanced chronic liver disease Y Mendoza, S Cocciolillo, G Murgia, T Chen, C Margini, G Sebastiani, ... Clinical Gastroenterology and Hepatology 18 (13), 3017-3025. e6, 2020 | 21 | 2020 |
| Non-invasive tools for compensated advanced chronic liver disease and portal hypertension after Baveno VII–an update D Segna, YP Mendoza, NF Lange, SG Rodrigues, A Berzigotti Digestive and liver disease 55 (3), 326-335, 2023 | 20 | 2023 |
| Risks and rewards of bariatric surgery in advanced chronic liver diseases YP Mendoza, C Becchetti, KD Watt, A Berzigotti Seminars in liver disease 41 (04), 448-460, 2021 | 16 | 2021 |
| Guía de práctica clínica para la enfermedad hepática grasa no alcohólica OA Beltrán Galvis, A Galindo, Y Mendoza, G Hernández, A Varón, ... Revista colombiana de Gastroenterología 30, 89-96, 2015 | 15 | 2015 |
| Malnutrition and alcohol in patients presenting with severe complications of cirrhosis after laparoscopic bariatric surgery YP Mendoza, C Becchetti, T Wan, P Nett, SG Rodrigues, JF Dufour, ... Obesity surgery 31, 2817-2822, 2021 | 13 | 2021 |
| Effect of poorly absorbable antibiotics on hepatic venous pressure gradient in cirrhosis: A systematic review and meta-analysis YP Mendoza, SG Rodrigues, J Bosch, A Berzigotti Digestive and Liver Disease 52 (9), 958-965, 2020 | 13 | 2020 |
| FIB-4 improves LSM-based prediction of complications in overweight or obese patients with compensated advanced chronic liver disease YP Mendoza, M Shengir, J Bosch, G Sebastiani, A Berzigotti Clinical Gastroenterology and Hepatology 20 (10), 2396-2398. e3, 2022 | 6 | 2022 |
| Diagnostic accuracy of non‐invasive tests to screen for at‐risk MASH—An individual participant data meta‐analysis FE Mózes, JA Lee, Y Vali, EA Selvaraj, ANA Jayaswal, J Boursier, ... Liver international, 2024 | 4 | 2024 |
| Simple blood tests to diagnose compensated advanced chronic liver disease and stratify risk of clinically significant portal hypertension G Semmler, L Hartl, YP Mendoza, B Simbrunner, M Jachs, L Balcar, ... Hepatology, 10.1097, 2024 | 2 | 2024 |
| Investigational drugs in early clinical development for portal hypertension SG Rodrigues, YP Mendoza, J Bosch Expert opinion on investigational drugs 31 (8), 825-842, 2022 | 2 | 2022 |
| Simple non-invasive surrogates of portal hypertension predict clinical decompensation in overweight/obese patients with cACLD YP Mendoza Alcohol 7 (6.7), 8.0, 2019 | 2 | 2019 |
| Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in … M Jachs, A Odriozola, F Turon, L Moga, L Téllez, P Fischer, D Saltini, ... The Lancet Gastroenterology & Hepatology, 2024 | 1 | 2024 |
| Metabolic phenotyping of patients with advanced chronic liver disease for better characterization of cirrhosis regression YP Mendoza, S Tsouka, G Semmler, P Seubnooch, K Freiburghaus, ... Journal of hepatology, 2024 | 1 | 2024 |
| Spleen stiffness measurement by a dedicated 100Hz vibration-controlled transient elastography probe improves the non-invasive diagnosis of clinically significant portal … M Jachs, P Fischer, A Odriozola, L Moga, WJ Kwanten, D Saltini, F Turon, ... Hepatology 78, S212-S214, 2023 | 1 | 2023 |
| Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease G Pennisi, M Enea, M Viganò, F Schepis, V de Ledinghen, A Berzigotti, ... JHEP reports 5 (9), 100809, 2023 | 1 | 2023 |
